Promis Neurosciences Inc
Healthcare · EUR · F
Price
€8.832
Cap
€88.15M
Earnings
—
30d Trend
-2.1%
35% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 43×Macro 0.99 (−1%)=43
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Medium-term outlook is neutral — no clear directional thesis
BRAIN47'S ASSESSMENT
I rate Promis Neurosciences Inc at 43/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 54/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+2.9%
3 MONTHS
—
12 MONTHS
—
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Medium-term outlook is neutral — no clear directional thesis. Fundamentals (54) and Technical (53) are the primary strengths. I note that quality is the weakest area at 15/100 — this warrants monitoring. Historical volatility is moderate at 35%. I classify this as a speculative position — risk characteristics and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.